Literature DB >> 20870921

Bladder Cancer Working Group report.

Yoshiyuki Kakehi1, Yoshihiko Hirao, Wun-Jae Kim, Seiichiro Ozono, Naoya Masumori, Naoto Miyanaga, Yasutomo Nasu, Akira Yokomizo.   

Abstract

EPIDEMIOLOGY OF BLADDER CANCER: Bladder cancer is the 7th most common cancer in men and the 17th most common in women in the world. The incidence of bladder cancer varies considerably among countries, with the highest incidence rates seen in Western countries and the lowest rates in Asian countries. In recent years, the mortality rate due to bladder cancer has been stable or decreased gradually. LIFESTYLE AND UROTHELIAL CARCINOMA: Occupational risks, environmental risks, dietary habits and cigarette smoking are lifestyle factors known to influence the development of urothelial carcinoma. Although the relative risk of bladder cancer associated with occupations is small, the public health impact may be significant. The Western pattern of diet is associated with a significant increase in the risk of bladder cancer. It has been found that smoking accounts for more than 50% of bladder cancers in men and 30% in women. Urological patients' awareness of smoking as a risk factor for bladder cancer is lower than their awareness regarding other smoking-related disease entities. Counseling patients regarding the risk of tobacco is a role for urologists. GENETIC SUSCEPTIBILITY TO UROTHELIAL CARCINOMA: Recent single-nucleotide polymorphism genetic studies in relation to bladder carcinogenesis have revealed several associated genetic polymorphisms of detoxification or DNA repair genes, such as NAT2, GST and OGG1. That information is important in relation to environmental risk factors and ethnic differences and will help predict the prognosis of patients with bladder cancer. Further studies are needed to confirm potential gene-gene and gene-environmental interactions leading to bladder carcinogenesis.

Entities:  

Mesh:

Year:  2010        PMID: 20870921     DOI: 10.1093/jjco/hyq128

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  25 in total

1.  Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.

Authors:  Meilin Wang; Haiyan Chu; Fu Yan; Chao Qin; Pu Li; Lin Yuan; Changjun Yin; Jianfeng Xu; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

2.  Alterations of microsatellite loci GSN and D18S51 in urinary bladder cancer.

Authors:  S Saidi; Z Popov; S Stavridis; S Panov
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

3.  Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.

Authors:  Naoto Kamiya; Hiroyoshi Suzuki; Takahito Suyama; Masayuki Kobayashi; Satoshi Fukasawa; Nobuyuki Sekita; Kazuo Mikami; Naoki Nihei; Yukio Naya; Tomohiko Ichikawa
Journal:  Int J Clin Oncol       Date:  2016-10-15       Impact factor: 3.402

4.  Quercetin-induced Growth Inhibition in Human Bladder Cancer Cells Is Associated with an Increase in Ca-activated K Channels.

Authors:  Yangmi Kim; Wun-Jae Kim; Eun-Jong Cha
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

5.  Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis.

Authors:  Isabelle N Colmers; Samantha L Bowker; Sumit R Majumdar; Jeffrey A Johnson
Journal:  CMAJ       Date:  2012-07-03       Impact factor: 8.262

6.  Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.

Authors:  C-H Tseng
Journal:  Diabetologia       Date:  2011-05-05       Impact factor: 10.122

7.  The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study.

Authors:  Haiyan Chu; Lan Ma; Meilin Wang; Danni Shi; Chao Qin; Lin Yuan; Changjun Yin; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2011-12-15       Impact factor: 2.316

Review 8.  Constitutional and occupational risk factors associated with bladder cancer.

Authors:  J Ferrís; J Garcia; O Berbel; J A Ortega
Journal:  Actas Urol Esp       Date:  2013-05-09       Impact factor: 0.994

9.  Bladder cancer epidemiology and genetic susceptibility.

Authors:  Haiyan Chu; Meilin Wang; Zhengdong Zhang
Journal:  J Biomed Res       Date:  2013-03-25

10.  Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.

Authors:  Yong Wang; He Wang; Wei Zhang; Chen Shao; Peng Xu; Chang Hong Shi; Jian Guo Shi; Yu Mei Li; Qiang Fu; Wei Xue; Yong Hua Lei; Jing Yu Gao; Juan Ying Wang; Xiao Ping Gao; Jin Qing Li; Jian Lin Yuan; Yun Tao Zhang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.